Clinical investigation of isolated bacteria from urinary tracts of hospitalized patients and their susceptibilities to antibiotics

[1]  Yoshitsugu Linuma.  [Infection control strategies for antimicrobial-resistance]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[2]  Baek-nam Kim,et al.  Three-Year Follow-up of an Outbreak of Serratia marcescens Bacteriuria in a Neurosurgical Intensive Care Unit , 2006, Journal of Korean medical science.

[3]  Kaori Tanaka,et al.  [Surveillance on Pseudomonas aeruginosa isolated in Gifu prefecture (2004)]. , 2006, The Japanese journal of antibiotics.

[4]  M. Svendsen,et al.  Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. , 2006, International journal of antimicrobial agents.

[5]  Y. Pei,et al.  Sg17-1-4, a Novel Isocoumarin from a Marine Fungus Alternaria tenuis Sg17-1 , 2006, The Journal of Antibiotics.

[6]  N. Shrestha,et al.  Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. , 2006, Singapore medical journal.

[7]  S. Bhattacharya.  ESBL - from petri dish to the patient. , 2006, Indian journal of medical microbiology.

[8]  L. Nicolle.  Catheter-Related Urinary Tract Infection , 2005, Drugs & aging.

[9]  K. Naber,et al.  New drugs for Gram-positive uropathogens. , 2004, International journal of antimicrobial agents.

[10]  A. Schaeffer,et al.  Current concepts in urinary tract infections. , 2004, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[11]  N. Taneja,et al.  Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. , 2004, The Indian journal of medical research.

[12]  D. Hoban,et al.  Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). , 2003, The Journal of antimicrobial chemotherapy.

[13]  H. Gold.  Vancomycin-resistant enterococci: mechanisms and clinical observations. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J W Warren,et al.  Catheter-associated urinary tract infections. , 1997, International journal of antimicrobial agents.

[15]  P. Tambyah,et al.  The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. , 2000, Archives of internal medicine.

[16]  Murray Be.  Problems and perils of vancomycin resistant enterococci. , 2000 .

[17]  B. Murray.  Problems and perils of vancomycin resistant enterococci. , 2000, Brazilian Journal of Infectious Diseases.

[18]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[19]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[20]  T. Hooton,et al.  Management of urinary tract infections in adults. , 1993, The New England journal of medicine.

[21]  A. Ronald,et al.  The natural history of urinary infection in adults. , 1991, The Medical clinics of North America.

[22]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[23]  W. Schaffner,et al.  An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. , 1976, The Journal of infectious diseases.